Alector to host virtual R&D event on ABC blood-brain barrier platform and neurodegeneration pipeline
Bitget2026/10/07 20:05Alector will host a virtual R&D event on Oct. 13, 2026 at 8:00 a.m. PT. Focus will be the wholly owned Alector Brain Carrier blood-brain barrier platform. Program updates will cover AL137, AL164, AL062, with additional discussion of ADP065. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alector Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610071605PRIMZONEFULLFEED9841439) on October 07, 2026, and is solely responsible for the information contained therein.
- Alector will host a virtual R&D event on Oct. 13, 2026 at 8:00 a.m. PT.
- Focus will be the wholly owned Alector Brain Carrier blood-brain barrier platform.
- Program updates will cover AL137, AL164, AL062, with additional discussion of ADP065.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cosan Publishes Q3 2026 Earnings Call Transcript
Forex Today: Japan CPI alongside UK consumer spending data will set the tone